Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11C]ER-176 Imaging of TSPO in Healthy Subjects
NCT02147392Phase 1Completed
- Sponsor
- National Institute of Mental Health
- Start
- May 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of [11C]ER176 (2 arms), sponsored by National Institute of Mental Health. Primary endpoints: Identifiability and time stability of distribution volume at 1 year and Genotype sensitivity of [11C]ER-176 at 1 year. Started May 2014; status: completed.
02
Drugs
[11C]ER176
Beyond the preview
Go deeper on NCT02147392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147392.